We found that SOD1-mutated ALS patients carrying the p.H63D polymorphism of HFE have a significantly longer median survival compared to non-carriers, and the result is independent of sex, age at onset, site of onset, positive family history, nation of origin, and severity of mutations. Here, SOD1 is linked to amyotrophic lateral sclerosis.